Author

I. Chinen

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:E. coli· 2 Research Focus:cell type annotation· 1 Assay:clinical cohort / trial· 1 Approach:deep learning· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Lopez Casanello· 1 shared A. Suarez· 1 shared A. Tamborini· 1 shared C. Carbonari· 1 shared D. J. Arrigo· 1 shared E. Manfredi· 1 shared E. Miliwebsky· 1 shared E. S. Miliwebsky· 1 shared

Activity by Year

2021-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. Lopez Casanello

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Rapid and accurate identification of Escherichia coli STEC O157:H7 by mass spectrometry, artificial intelligence and detection of specific biomarkers peaks.

E. Manfredi, F. Rocca, J. Zintgraff, L. Irazu, E. Miliwebsky, C. Carbonari, N. Deza, M. Prieto, I. Chinen

This paper develops a method using mass spectrometry, biomarkers, and AI to accurately identify STEC O157:H7 from other diarrheagenic E. coli with high sensitivity and specificity.

bioRxiv · Mar 31, 2022 · PreprintMicrobiology

Surveillance of Shiga toxin-producing Escherichia coli associated bloody diarrhea in Argentina

M. Rivas, M. Pichel, M. Colonna, A. Lopez Casanello, L. Alconcher, J. Galavotti, I. Prinicipi, S. Perez Araujo, F. B. Ramirez, G. Gonzalez, L. Pianciola, M. Mazzeo, A. Suarez, S. Oderiz, L. F. Ghezzi, , E. TEAM

The paper investigates STEC-associated bloody diarrhea and progression to HUS in children in Argentina, finding 4.1% STEC-positive cases and 13.8% progressing to HUS.

bioRxiv · Jan 7, 2021Microbiology